摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-碘-1-三苯基咪唑 | 67478-46-0

中文名称
2-碘-1-三苯基咪唑
中文别名
2-碘-1-三苯甲基-1H-咪唑
英文名称
2-iodo-1-trityl-1H-imidazole
英文别名
2-iodo-1-tritylimidazole
2-碘-1-三苯基咪唑化学式
CAS
67478-46-0
化学式
C22H17IN2
mdl
MFCD02179529
分子量
436.295
InChiKey
AAHIYUWXFHXGBO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    170-171℃

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.045
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2933290090

SDS

SDS:a7ed079b557961024c9f4766af6a7b28
查看
Material Safety Data Sheet

Section 1. Identification of the substance
2-Iodo-1-trityl-1H-imidazole
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

Section 3. Composition/information on ingredients.
Ingredient name: 2-Iodo-1-trityl-1H-imidazole
CAS number: 67478-46-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
This product should be handled only by, or under the close supervision of, those properly qualified
Handling:
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C22H17IN2
Molecular weight: 436.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-碘-1-三苯基咪唑溶剂黄146 作用下, 以 为溶剂, 反应 5.0h, 以88%的产率得到2-碘咪唑
    参考文献:
    名称:
    Palladium-Catalyzed Intramolecular Arylation of N-Benzyl-2-iodoimidazoles: A Facile and Rapid Access to 5H-Imidazo[2,1-a]isoindoles
    摘要:
    首次报道了一种钯催化下的咪唑环C-2位点参与的分子内芳基化反应。应用此反应,可以一步从N-苄基-2-碘咪唑合成5H-咪唑并[2,1-a]异吲哚。微波辐照加速了反应速率,使得多种咪唑并[2,1-a]异吲哚类似物的合成成为可能。
    DOI:
    10.1055/s-2007-965896
  • 作为产物:
    描述:
    N-三苯甲基咪唑正丁基锂 作用下, 以 四氢呋喃 为溶剂, 反应 0.5h, 以88%的产率得到2-碘-1-三苯基咪唑
    参考文献:
    名称:
    Palladium-Catalyzed Intramolecular Arylation of N-Benzyl-2-iodoimidazoles: A Facile and Rapid Access to 5H-Imidazo[2,1-a]isoindoles
    摘要:
    首次报道了一种钯催化下的咪唑环C-2位点参与的分子内芳基化反应。应用此反应,可以一步从N-苄基-2-碘咪唑合成5H-咪唑并[2,1-a]异吲哚。微波辐照加速了反应速率,使得多种咪唑并[2,1-a]异吲哚类似物的合成成为可能。
    DOI:
    10.1055/s-2007-965896
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES CUTANÉS
    申请人:KAMARI PHARMA LTD
    公开号:WO2021154966A1
    公开(公告)日:2021-08-05
    Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.
    提供了一种公式(XXXII)的化合物或药用可接受的盐、溶剂化物、合物、立体异构体或生理功能衍生物,其中R1、R2、R3、G、A、E、n、p和q在此定义。此外,还提供了包含公式(XXXII)化合物的组合物,以及使用公式(XXXII)化合物的方法,例如,在治疗或预防皮肤病中的应用。
  • FRICTIONLESS MOLECULAR ROTARY MOTORS
    申请人:Keinan Ehud
    公开号:US20100016610A1
    公开(公告)日:2010-01-21
    A rotaxane consisting of a cucurbituril and an uncharged guest molecule, having low or null affinity therebetween is provided as well as processes for providing the same. Various uses as energy converters (“frictionless” molecular motors), biochips and biosensors using the same are also provided.
    提供了由葫芦醚和一个不带电的客体分子组成的轮烷,并提供了它们之间具有低或无亲和力的过程。还提供了使用这种轮烷作为能量转换器(“无摩擦”分子马达)、生物芯片和生物传感器的各种用途。
  • 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES
    申请人:Aissaoui Hamed
    公开号:US20100093740A1
    公开(公告)日:2010-04-15
    The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I), wherein X represents CH 2 or O; R 1 represents a phenyl group, which group is independently mono-, di-, or tri-substituted wherein the substituents are independently selected from the group consisting of (C 1-4 )alkyl, (C 1-4 )alkoxy, halogen, cyano, trifluoromethoxy and trifluoromethyl; R 2 represents (C 1-4 )alkyl, (C 1-4 )alkoxy, (C 2-4 )alkenyl, halogen, cyano, hydroxymethyl, trifluoromethyl, C(O)NR 5 R 6 or cyclopropyl; R 3 represents (C 1-4 )alkyl, (C 1-4 )alkoxy-methyl or halogen; R 4 represents (C 1-4 )alkyl; R 5 represents hydrogen or (C 1-4 )alkyl; and R 6 represents hydrogen or (C 1-4 )alkyl. The invention also relates to pharmaceutically acceptable salts of such compounds; and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
    本发明涉及公式(I)的5,6,7,8-四氢咪唑[1,5-a]吡嗪生物,其中X代表CH2或O; R1代表苯基,该基团独立地单取代、双取代或三取代,其中取代基独立地选自由(C1-4)烷基,(C1-4)烷氧基,卤素,基,三甲氧基和三甲基的群组; R2代表(C1-4)烷基,(C1-4)烷氧基,(C2-4)烯基,卤素,基,羟甲基,三甲基,C(O)NR5R6或环丙基; R3代表(C1-4)烷基,(C1-4)烷氧甲基或卤素; R4代表(C1-4)烷基; R5代表氢或(C1-4)烷基; R6代表氢或(C1-4)烷基。本发明还涉及这种化合物的药学上可接受的盐;以及将这种化合物用作药物的用途;特别是作为促进睡眠激素受体拮抗剂。
  • [EN] WDR5 INHIBITORS AND MODULATORS<br/>[FR] MODULATEURS ET INHIBITEURS DE WDR5
    申请人:UNIV VANDERBILT
    公开号:WO2020086857A8
    公开(公告)日:2020-11-12
  • Coutts, Ian G. C.; Jieng, Shende; Khandelwahl, Ghanshyam D., Journal of Heterocyclic Chemistry, 1994, vol. 31, # 4, p. 857 - 860
    作者:Coutts, Ian G. C.、Jieng, Shende、Khandelwahl, Ghanshyam D.、Wood, Michael L.
    DOI:——
    日期:——
查看更多

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 重氮四苯基乙烷 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲醇,2-氨基-5-氯-a-乙烯基-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲酸,3-[[2-[[(1,1-二甲基乙氧基)羰基]氨基]-3-[(三苯代甲基)硫代]丙基]氨基]-,(R)- 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 苄基 2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷 芴甲氧羰基-4-叔丁酯-天冬酰胺-S-三氯苯甲基-L-半胱氨酸 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磺基琥珀酰亚胺基-4-[2-(4,4-二甲氧基三苯甲基)]丁酸酯 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-6-O-三苯甲基-beta-D-吡喃半乳糖苷 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷